Potent tumor-directed T cell activation and tumor inhibition induced by ALG.APV-527, a 4-1BB x 5T4 ADAPTIR™ bispecific antibody

被引：0
|
作者：
Nelson, Michelle H. [1 ]
Miller, Robert [1 ]
Bader, Robert [1 ]
Werchau, Doreen [2 ]
Nilsson, Anneli [2 ]
Ljung, Lill [2 ]
Deronic, Adnan [2 ]
Chunyk, Allison [1 ]
Schultz, Lena [2 ]
McMahan, Catherine [1 ]
Bienvenue, David [1 ]
Dahlman, Anna [2 ]
Fritzell, Sara [2 ]
Askmyr, Maria [1 ]
Hernandez-Hoyos, Gabriela [1 ]
机构：
[1] Aptevo Therapeut Inc, Seattle, WA USA
[2] Alligator Biosci AB, Lund, Sweden
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P642
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A novel tumor-targeted 4-1BB agonist and its combination with T-cell bispecific antibodies: an off-the-shelf cancer immunotherapy alternative to CAR T-cells
    Claus, Christina
    Ferrara, Claudia
    Lang, Sabine
    Albrecht, Rosmarie
    Herter, Sylvia
    Amann, Maria
    Richards-Grau, Sandra
    Sam, Johannes
    Colombetti, Sara
    Bacac, Marina
    Klein, Christian
    Umana, Pablo
    CANCER RESEARCH, 2017, 77
  • [42] A trispecific antibody induces potent tumor-directed T-cell activation and antitumor activity by CD3/CD28 co-engagement
    Chen, Li
    Qian, Wenjing
    Pan, Fangfang
    Li, Debin
    Yu, Weiwei
    Tong, Li
    Yang, Yingying
    Xu, Qiming
    Ding, Jianfeng
    Dai, Ruixue
    Xian, Weiwei
    Zhu, Xufeng
    Ren, Pu
    Zhu, Huaxing
    IMMUNOTHERAPY, 2024, 16 (03) : 143 - 159
  • [43] Improving Tumor Infiltrating Lymphocyte Survival, Function for Melanoma Adoptive T-cell Therapy Through 4-1BB Costimulation
    Hernandez, Jessica A.
    Li, Yufeng
    Wang, Yijun
    Hwu, Patrick
    Radvanyi, Laszlo
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 944 - 944
  • [44] Optimal Activation of Both CD28 and 4-1BB in CAR-Targeted T Cells Results in Enhanced Tumor Eradication
    Zhao, Zeguo
    van der Stegen, Sjoukje J. C.
    Condomines, Maud
    Perna, Fabiana
    Gunset, Gertrude
    Plotkin, Jason
    Sadelain, Michel
    MOLECULAR THERAPY, 2015, 23 : S82 - S82
  • [45] 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
    Kim, Hyung-Don
    Park, Seongyeol
    Jeong, Seongju
    Lee, Yong Joon
    Lee, Hoyoung
    Kim, Chang Gon
    Kim, Kyung Hwan
    Hong, Seung-Mo
    Lee, Jung-Yun
    Kim, Sunghoon
    Kim, Hong Kwan
    Min, Byung Soh
    Chang, Jong Hee
    Ju, Young Seok
    Shin, Eui-Cheol
    Song, Gi-Won
    Hwang, Shin
    Park, Su-Hyung
    HEPATOLOGY, 2020, 71 (03) : 955 - 971
  • [46] Long-term Tumor Regression Induced by an Antibody-Drug Conjugate That Targets 5T4, an Oncofetal Antigen Expressed on Tumor-Initiating Cells
    Sapra, Puja
    Damelin, Marc
    DiJoseph, John
    Marquette, Kimberly
    Geles, Kenneth G.
    Golas, Jonathon
    Dougher, Maureen
    Narayanan, Bitha
    Giannakou, Andreas
    Khandke, Kiran
    Dushin, Russell
    Ernstoff, Elana
    Lucas, Judy
    Leal, Mauricio
    Hu, George
    O'Donnell, Christopher J.
    Tchistiakova, Lioudmila
    Abraham, Robert T.
    Gerber, Hans-Peter
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (01) : 38 - 47
  • [47] ATG-101 Is a Tetravalent PD-L1x4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1-Directed 4-1BB Activation
    Hui, Yuwen
    Wang, Huajing
    Li, Tengteng
    Ren, Yijing
    Zhang, Yun-kai
    Chen, Peng
    Sun, Ao
    Bian, Gang
    Li, Bohua
    Flowers, David
    Presler, Marc
    Subramanian, Kalyanasundaram
    Xue, Jia
    Wang, Jingjing
    Lynch, Kevin
    Mei, Jay
    He, Xiaowen
    Shan, Bo
    Hou, Bing
    CANCER RESEARCH, 2024, 84 (10) : 1680 - 1698
  • [48] Long-term tumor regression induced by a novel antibody drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells
    Sapra, Puja
    DiJoseph, John
    Damelin, Marc
    Dougher, Maureen
    Narayanan, Bitha
    Khandke, Kiran
    Lucas, Judy
    Goias, Jon
    Tchistiakoya, Lioudmila
    Lea, Mauricio
    Hui, George
    Maderna, Andreas
    Marquette, Kimberly
    Loganzo, Frank
    Dushin, Russell
    O'Donne, Christopher J.
    Abraham, Robert
    Gerber, Hans-Peter
    CANCER RESEARCH, 2012, 72
  • [49] Signals through 4-1BB prevent activation-induced cell death of previously activated splenic T cells.
    Hurtado, JC
    Kim, YJ
    Kwon, BS
    FASEB JOURNAL, 1996, 10 (06): : 418 - 418
  • [50] Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
    Hurtado, JC
    Kim, YJ
    Kwon, BS
    JOURNAL OF IMMUNOLOGY, 1997, 158 (06): : 2600 - 2609
12345